These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 24173599)
1. When depression doesn't lead with depression. Miller MC JAMA Psychiatry; 2013 Nov; 70(11):1131-2. PubMed ID: 24173599 [No Abstract] [Full Text] [Related]
3. Increased prefrontal cortex activity during negative emotion regulation as a predictor of depression symptom severity trajectory over 6 months. Heller AS; Johnstone T; Peterson MJ; Kolden GG; Kalin NH; Davidson RJ JAMA Psychiatry; 2013 Nov; 70(11):1181-9. PubMed ID: 24173657 [TBL] [Abstract][Full Text] [Related]
4. The brain tells: early signs of depression recovery. Harv Ment Health Lett; 2002 Nov; 19(5):6. PubMed ID: 12453746 [No Abstract] [Full Text] [Related]
5. Overt irritability/anger in unipolar major depressive episodes: past and current characteristics and implications for long-term course. Judd LL; Schettler PJ; Coryell W; Akiskal HS; Fiedorowicz JG JAMA Psychiatry; 2013 Nov; 70(11):1171-80. PubMed ID: 24026579 [TBL] [Abstract][Full Text] [Related]
6. Prefrontal changes and treatment response prediction in depression. Cook IA; Leuchter AF Semin Clin Neuropsychiatry; 2001 Apr; 6(2):113-20. PubMed ID: 11296311 [TBL] [Abstract][Full Text] [Related]
7. Personality disorders improve in patients treated for major depression. Mulder RT; Joyce PR; Frampton CM Acta Psychiatr Scand; 2010 Sep; 122(3):219-25. PubMed ID: 19895619 [TBL] [Abstract][Full Text] [Related]
8. Irritability in depression can be a symptom of mixed depression. Benazzi F Acta Psychiatr Scand; 2010 Jan; 121(1):80; author reply 80. PubMed ID: 20059455 [No Abstract] [Full Text] [Related]
9. Reduced right ventrolateral prefrontal cortex activity while inhibiting positive affect is associated with improvement in hedonic capacity after 8 weeks of antidepressant treatment in major depressive disorder. Light SN; Heller AS; Johnstone T; Kolden GG; Peterson MJ; Kalin NH; Davidson RJ Biol Psychiatry; 2011 Nov; 70(10):962-8. PubMed ID: 21867991 [TBL] [Abstract][Full Text] [Related]
10. Combining antidepressant medications: a good idea? Rush AJ Am J Psychiatry; 2010 Mar; 167(3):241-3. PubMed ID: 20194484 [No Abstract] [Full Text] [Related]
11. Predictors of improved mood over time in clinical trials for major depression. Marie-Mitchell A; Leuchter AF; Chou CP; James Gauderman W; Azen SP Psychiatry Res; 2004 Jun; 127(1-2):73-84. PubMed ID: 15261707 [TBL] [Abstract][Full Text] [Related]
12. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. Amsterdam JD; Wang CH; Shwarz M; Shults J J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235 [TBL] [Abstract][Full Text] [Related]
13. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946 [TBL] [Abstract][Full Text] [Related]
14. Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons. Eckert L; Lançon C BMC Psychiatry; 2006 Jul; 6():30. PubMed ID: 16867188 [TBL] [Abstract][Full Text] [Related]
15. Does prior antidepressant treatment of major depression impact brain function during current treatment? Hunter AM; Cook IA; Leuchter AF Eur Neuropsychopharmacol; 2012 Oct; 22(10):711-20. PubMed ID: 22445212 [TBL] [Abstract][Full Text] [Related]
16. Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression. Lawrence NS; Williams AM; Surguladze S; Giampietro V; Brammer MJ; Andrew C; Frangou S; Ecker C; Phillips ML Biol Psychiatry; 2004 Mar; 55(6):578-87. PubMed ID: 15013826 [TBL] [Abstract][Full Text] [Related]
17. QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder. Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Höschl C Clin EEG Neurosci; 2015 Apr; 46(2):73-80. PubMed ID: 24711613 [TBL] [Abstract][Full Text] [Related]
18. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project. McIntyre RS; Soczynska JK; Cha DS; Woldeyohannes HO; Dale RS; Alsuwaidan MT; Gallaugher LA; Mansur RB; Muzina DJ; Carvalho A; Kennedy SH J Affect Disord; 2015 Feb; 172():259-64. PubMed ID: 25451425 [TBL] [Abstract][Full Text] [Related]
19. Bipolar mood disorders among Polish psychiatric outpatients treated for major depression. Rybakowski JK; Suwalska A; Lojko D; Rymaszewska J; Kiejna A J Affect Disord; 2005 Feb; 84(2-3):141-7. PubMed ID: 15708411 [TBL] [Abstract][Full Text] [Related]
20. Changes in brain function of depressed subjects during treatment with placebo. Leuchter AF; Cook IA; Witte EA; Morgan M; Abrams M Am J Psychiatry; 2002 Jan; 159(1):122-9. PubMed ID: 11772700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]